Drug Type Prophylactic vaccine |
Synonyms VSARS |
Target |
Action inhibitors |
Mechanism SARS-CoV-2 antigen inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Phase 2 | Canada | 15 May 2020 | |
COVID-19 | Phase 2 | Mongolia | 15 May 2020 |